DiviDrip · BIVI

BIVI — BioVie Inc.

BIVI is BioVie Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.16. Market cap: $18M. Capital Quality Rank: 42/100 — Stagnant mediocrity.

Stock snapshot

Price$2.16
Market cap$18M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)42 / 100 · Stagnant mediocrity
ROIC (TTM)-531.0%
Shareholder buyback yield0.00%
Altman Z-score zoneDistress

About BIVI

BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenetics. In liver disease, its investigational drug candidate BIV201 (continuous infusion terlipressin) was granted FDA Fast Track status and FDA Orphan Drug designation for ascites due to all etiologies except cancer. BIV201 is being evaluated as a treatment option for patients suffering from life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.

Listed2014Employees13HQCarson City, NVSectorHealthcareWebsitebioviepharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside BIVI. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is BIVI's current stock price?

BIVI (BioVie Inc.) is currently trading at $2.16.

Does BIVI pay a dividend?

BIVI (BioVie Inc.) does not currently pay a regular dividend.

What is BIVI's Capital Quality Rank?

BIVI has a Capital Quality Rank of 42/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track BIVI in DiviDrip

Add BIVI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow